Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

KOSDAQ/032300 stock hub

KOSDAQ/032300 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KOSDAQ/032300is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

120.8B

KOSDAQ

Market data

Live price

Current market quote for this ticker.

Current price

KOSDAQ/032300

In the news

Latest news · KOSDAQ/032300

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-3.8

P25 n/aP50 n/aP75 n/a

ROIC-1.1

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KOSDAQ/032300 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

189

Groups with data

Currency

KRW

Showing 189 of 189 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	134
Enterprise value	KRW 132.3B
Exchange	KOSDAQ
Financial currency	KRW
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	KRW 120.8B
Price	KRW 11,080
Price currency	KRW
Rev Per Employee	653,741,619.78x
Sic	2834
Symbol	kosdaq/032300
Website	https://www.koreapharma.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.18%
EV Earnings	-50.09x
EV/EBITDA	66.08x
EV/FCF	-7.8x
EV/Sales	1.51x
FCF yield	-14.03%
P/B ratio	1.76x
P/S ratio	1.38x
PE Ratio3 Y	558.18x
PE Ratio5 Y	341.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-1.01%
EBITDA Margin	2.6%
Gross margin	35.81%
Gross Profit	KRW 31.4B
Gross Profit Growth	-10.75%
Gross Profit Growth Q	-39.02%
Gross Profit Growth3 Y	-3.96%
Gross Profit Growth5 Y	-1.68%
Net Income	KRW -2.6B
Pretax Margin	-5.16%
Profit Margin	-3.01%
Profit Per Employee	KRW -19.7M
ROA	-0.46
Roa5y	2.33
ROCE	-1.27
ROE	-3.77
Roe5y	2.42
ROIC	-1.14
Roic5y	6.64

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-21.63%
Cagr3y	-18.15%
Cagr5y	-24.77%
Div CAGR3	0%
Div CAGR5	0%
OCF Growth	-66.61%
OCF Growth10 Y	4.79%
OCF Growth3 Y	-31.28%
Revenue Growth	7.78x
Revenue Growth Q	-11.44x
Revenue Growth3 Y	2.63x
Revenue Growth5 Y	4.14x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.73
Assets	KRW 126.6B
Cash	KRW 27.5B
Current Assets	KRW 64.4B
Current Liabilities	KRW 56.6B
Debt	KRW 38.9B
Debt EBITDA	KRW 17.08
Debt Equity	KRW 0.57
Debt FCF	KRW -2.3
Equity	KRW 68.8B
Interest Coverage	-0.25
Liabilities	KRW 57.9B
Long Term Assets	KRW 62.3B
Long Term Liabilities	KRW 1.3B
Net Cash	KRW -11.4B
Net Cash By Market Cap	KRW -9.44
Net Debt EBITDA	KRW 5
Net Debt Equity	KRW 0.17
Tangible Book Value	KRW 65.4B
Tangible Book Value Per Share	KRW 5,992
WACC	8.11

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.14
Inventory Turnover	2.74
Net Working Capital	KRW 18.5B
Quick ratio	0.74
Working Capital	KRW 7.8B
Working Capital Turnover	KRW 2.82

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.14%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	KRW 50
Dividend Years	6
Dividend Yield	0.45%
Ex Div Date	2025-12-29
Last Dividend	KRW 50
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-21.62%
200-day SMA	13,226.4
3Y total return	-45.18%
50-day SMA	11,833.6
50-day SMA vs 200-day SMA	50under200
5Y total return	-75.89%
All Time High	94,800
All Time High Change	-88.31%
All Time High Date	2021-01-21
All Time Low	10,780
All Time Low Change	2.78%
All Time Low Date	2026-04-06
ATR	359.8
Beta	0.75
Beta1y	0.5
Beta2y	0.55
Ch YTD	-14.77
High	11,290
High52	18,710
High52 Date	2025-06-12
High52ch	-40.78%
Low	11,010
Low52	10,780
Low52 Date	2026-04-07
Low52ch	2.78%
Ma50ch	-6.37%
Price vs 200-day SMA	-16.23%
RSI	39.86
RSI Monthly	37.44
RSI Weekly	37.04
Sharpe ratio	-0.94x
Sortino ratio	-1.14
Total Return	0.32%
Tr YTD	-14.77
Tr1m	1.84%
Tr1w	-3.48%
Tr3m	-6.1%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW -887.3M
Operating margin	-1.01

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,994,512%
Net Borrowing	11,276,925,600
Shares Insiders	63.38%
Shares Institutions	0.01%
Shares Out	10,906,701
Shares Qo Q	0.15%
Shares Yo Y	0.14%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -17B
Average Volume	22,800.1x
Bv Per Share	6,297.4
CAPEX	KRW -19.6B
Ch1m	1.84
Ch1w	-3.48
Ch1y	-21.92
Ch3m	-6.1
Ch3y	-45.69
Ch5y	-76.2
Ch6m	-15.29
Change	-0.18%
Change From Open	-0.36
Close	11,100
Days Gap	0.18
Depreciation Amortization	3,166,874,600
Dollar Volume	188,360,000
EBIT	KRW -887.3M
EBITDA	KRW 2.3B
EPS	KRW -242
F Score	3
FCF	KRW -17B
FCF EV Yield	-12.82x
FCF Per Share	KRW -1,555
Financing CF	10,731,590,540
Fiscal Year End	December
Founded	1,974
Income Tax	KRW -1.9B
Investing CF	-7,779,068,740
Is Primary Listing	1
Last Report Date	2025-12-31
Ma150	12,779.5
Ma150ch	-13.3%
Ma20	11,566
Ma20ch	-4.2%
Net CF	5,621,164,480
Open	11,120
P OCF Ratio	44.98
Payment Date	2026-04-24
Position In Range	25
Ppne	22,913,625,120
Price Date	2026-05-08
Price EBITDA	KRW 53.01
Ptbv Ratio	1.85
Relative Volume	0.75x
Revenue	87,601,377,050x
Tax By Revenue	-2.15x
Tr6m	-14.96%
Volume	17,000
Z Score	2.62

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

KOSDAQ/032300 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.5%

$50.0 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

0.0%

0 consecutive years of growth

Total shareholder yield

+0.3%

Next ex-dividend date: 2025-12-29

Performance

KOSDAQ/032300 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KOSDAQ/032300?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.0%

Share of float held by funds and institutions

Insider ownership

+63.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

KOSDAQ/032300 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

39.9

Neutral momentum band

Price vs 200-day MA

-16.2%

50/200-day relationship not available

Beta (5Y)

0.75

Less volatile than the market

Sharpe ratio

-0.94

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KOSDAQ/032300

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/032300 stock rating?

kosdaq/032300 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/032300 analysis?

The full report lives at /stocks/kosdaq/032300/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/032300?

The latest report frames kosdaq/032300 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/032300 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.